Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

The role of leukotrienes in allergic rhinitis.

Peters-Golden M, Henderson WR Jr.

Ann Allergy Asthma Immunol. 2005 Jun;94(6):609-18; quiz 618-20, 669. Review.

PMID:
15984591
3.

Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis.

Figueroa DJ, Borish L, Baramki D, Philip G, Austin CP, Evans JF.

Clin Exp Allergy. 2003 Oct;33(10):1380-8.

PMID:
14519144
4.

Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis.

Peters-Golden M, Gleason MM, Togias A.

Clin Exp Allergy. 2006 Jun;36(6):689-703. Review.

5.

A review of montelukast in the treatment of asthma and allergic rhinitis.

Nayak A.

Expert Opin Pharmacother. 2004 Mar;5(3):679-86. Review.

PMID:
15013935
6.

Cysteinyl leukotrienes induce nasal symptoms of allergic rhinitis via a receptor-mediated mechanism in guinea pigs.

Fujita M, Nakagawa N, Yonetomi Y, Takeda H, Kawabata K, Ohno H.

Jpn J Pharmacol. 1997 Dec;75(4):355-62.

7.

Effects of a cysteinyl leukotriene receptor antagonist on eosinophil recruitment in experimental allergic rhinitis.

Saito H, Morikawa H, Howie K, Crawford L, Baatjes AJ, Denburg E, Cyr MM, Denburg JA.

Immunology. 2004 Oct;113(2):246-52.

8.

Allergic rhinitis: not purely a histamine-related disease.

Howarth PH, Salagean M, Dokic D.

Allergy. 2000;55 Suppl 64:7-16. Review.

9.

The role of leukotrienes in upper and lower airway inflammation and the implications for treatment.

Borish L.

Ann Allergy Asthma Immunol. 2002 Apr;88(4 Suppl 1):16-22. Review.

PMID:
11991545
10.

Montelukast in the treatment of allergic rhinitis: an evidence-based review.

Nayak A, Langdon RB.

Drugs. 2007;67(6):887-901. Review.

PMID:
17428106
11.

The role of leukotrienes in nasal allergy.

Haberal I, Corey JP.

Otolaryngol Head Neck Surg. 2003 Sep;129(3):274-9. Review.

PMID:
12958580
12.

Intratracheal administration of anaphylatoxin C5a potentiates antigen-induced pulmonary reactions through the prolonged production of cysteinyl-leukotrienes.

Kodani M, Sakata N, Takano Y, Kamiya H, Katsuragi T, Hugli TE, Abe M.

Immunopharmacology. 2000 Sep;49(3):263-74.

PMID:
10996024
13.

Efficacy of leukotriene antagonists as concomitant therapy in allergic rhinitis.

Cingi C, Gunhan K, Gage-White L, Unlu H.

Laryngoscope. 2010 Sep;120(9):1718-23. doi: 10.1002/lary.20941.

PMID:
20717951
15.

Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa.

Shirasaki H, Kanaizumi E, Watanabe K, Matsui T, Sato J, Narita S, Rautiainen M, Himi T.

Clin Exp Allergy. 2002 Jul;32(7):1007-12.

PMID:
12100046
16.
17.

Leukotriene receptors in rhinitis and sinusitis.

Steinke JW, Borish L.

Curr Allergy Asthma Rep. 2004 May;4(3):217-23. Review.

PMID:
15056404
18.

Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.

Singh RK, Gupta S, Dastidar S, Ray A.

Pharmacology. 2010;85(6):336-49. doi: 10.1159/000312669. Epub 2010 Jun 2. Review.

19.

Cysteinyl leukotriene receptor CysLT1 as a novel therapeutic target for allergic rhinitis treatment.

Shirasaki H.

Expert Opin Ther Targets. 2008 Apr;12(4):415-23. doi: 10.1517/14728222.12.4.415 . Review.

PMID:
18348678
20.
Items per page

Supplemental Content

Write to the Help Desk